All Pharma News
GigaGen Receives FDA Clearance of IND to Begin Phase 1 Trial of GIGA-564

GigaGen Receives FDA Clearance of IND to Begin Phase 1 Trial of GIGA-564
GLOBENEWSWIRE
12 Dec 2023
Share Share
GigaGen Granted Expansion of Contract to Develop Synthetic Human Antibody

GigaGen Granted Expansion of Contract to Develop Synthetic Human Antibody
GLOBENEWSWIRE
19 Oct 2023
Share Share
GigaGen Partners with the National Cancer Institute to Advance Oncology Drug

GigaGen Partners with the National Cancer Institute to Advance Oncology Drug
GLOBENEWSWIRE
28 Sep 2023
Share Share
GigaGen’s use of 2G UNicTM tech extended by ProteoNic

GigaGen’s use of 2G UNicTM tech extended by ProteoNic
John Pinching PHARMATIMES
01 Nov 2022
Share Share
GigaGen Awarded Contract by U.S. Department of Defense to Discover Synthetic

GigaGen Awarded Contract by U.S. Department of Defense to Discover Synthetic
GLOBENEWSWIRE
15 Sep 2022
Share Share
GigaGen Publishes Research on Clinical GMP Manufacturing & IND-Enabling Studies

GigaGen Publishes Research on Clinical GMP Manufacturing & IND-Enabling Studies
GLOBENEWSWIRE
28 Jul 2022
Share Share
GigaGen Publishes Research on the Potential of its Machine Learning Platform

GigaGen Publishes Research on the Potential of its Machine Learning Platform
GLOBENEWSWIRE
19 May 2022
Share Share
GigaGen Publishes Research update on GIGA-564

GigaGen Publishes Research update on GIGA-564
GLOBENEWSWIRE
14 Jul 2021
Share Share
GigaGen Publishes Research on Company’s Recombinant Hyperimmunes

GigaGen Publishes Research on Company’s Recombinant Hyperimmunes
GLOBENEWSWIRE
15 Apr 2021
Share Share
GigaGen Initiates Large-Scale Manufacturing of Hyperimmune Drug for COVID-19

GigaGen Initiates Large-Scale Manufacturing of Hyperimmune Drug for COVID-19
GLOBENEWSWIRE
09 Sep 2020
Share Share